Plaintiff Withdraws Asbestos-In-Talc Claims On Trial Eve
Plaintiff Withdraws Asbestos-In-Talc Claims On Trial Eve
Introduction
A plaintiff, who sued Johnson & Johnson for his alleged mesothelioma from asbestos exposure, agreed to dismiss his claims on the eve of a South Carolina trial for the talcum lawsuit. In his lawsuit, the plaintiff blamed that asbestos presence in J&J's and Colgate-Palmolive's talcum powder products caused his fatal cancer. Additionally, he also stated he came in contact with asbestos at the workplace while working with industrial products.
J&J will face trial proceedings this month in Los Angeles Superior Court and Middlesex County Superior Court for allegations over its talcum powder causing ovarian cancer when used for personal hygiene. Asbestos exposure in manufacturing plants and mines has caused hazardous side-effects to several workers. Lawsuits filed against various industries claim the owners of not adequately warning about the risks of asbestos exposure to the workers.
Comments
Latest News
Attorneys Seek Reconsideration of Talc MDL Daubert Ruling
Categories: General
Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…
Philips resolves DreamStation suits for $1.1B
Categories: Settlements
Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…
FDA OKs Generic OTC Naloxone Spray Approved by FDA
Categories: FDA Related
The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.
…